Additionally, receptor tyrosine kinase fusions (FGFR2 fusions in intrahepatic CCA) or variations (EGFR, BRAF, etc.)can also funnel into MEK/ERK activation [48]. This evidence concerns the gene BRAF and cholangiocarcinoma.